SOMAÍ Pharmaceuticals

About:

A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint

Website: http://www.somaipharma.eu

Twitter/X: somaipharma

Top Investors: Portugal 2020

Description:

SOMAÍ Pharmaceuticals is a leading EU-GMP European pharmaceutical and biotech company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceuticals portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine. SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of the few vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.

Total Funding Amount:

37.7M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Dublin, Dublin, Ireland

Founded Date:

2019-01-24

Contact Email:

hello(AT)somaipharma.eu

Founders:

George Bellow, Michael Sassano

Number of Employees:

101-250

Last Funding Date:

2024-07-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai